NicolaYJ

Lets change science!

[Avacta @avacta]

Ask a scientist why they stay in oncology and you will usually hear about a "wow moment". The people behind pre|CISION® share theirs, from the first tumor to plasma data to a new molecule from idea to IND in 12 months. Watch the video here: https://t.co/yQYPRuyU6Y #AVCT

[NicolaYJ @NicBongette]

@coughlin582 @avacta “never doubt that a small group of thoughtful, committed citizens can change the world. Indeed it is the only thing that ever has”

#AVCT

[NicolaYJ @NicBongette]

@Ophidian18 and every two weeks not three - great update.

#AVCT

[NicolaYJ @NicBongette]

@tom_the_bomb__ @asininitybeyond @RAH00084 @Novartis @avacta It is also a deal that Alastair Smith has quoted previously.

#AVCT

[NicolaYJ @NicBongette]

"pre|CISION is absolutely specific to FAP
which is Avacta's Intellectual property (IP)".

#AVCT

[NicolaYJ @NicBongette]

@MylesMcNulty @avacta So much to be excited about on the RNS but this is important too: Age, median (range) 65 (30-79)

AS told us that they don't give Dox to people over 65! Expanding the patients we can actually help with AVA6000 is so vital. Its often over 65's that get cancer! #AVCT

[NicolaYJ @NicBongette]

@Tim60829857 @LittleGunner5 @Smiffy_O You know the results already - IT WORKS!

#AVCT

[Investor Meet Company @InvestorMeetCo]

Join AVACTA GROUP PLC's Review of the AVA6000 clinical trial’s Phase 1a data on 13th Dec 2023 at 11:00am GMT, Click below to register. #AVCT avacta
https://t.co/X09yeik1RI

[NicolaYJ @NicBongette]

@tom_the_bomb__ @AndrewDigby3 FOMO for PI and BP Tom.
No more squabbling, get your bids in!
#AVCT
@tom_the_bomb__

[NicolaYJ @NicBongette]

#AVCT
If you don't understand yet, read this.

"These data continue to demonstrate the potential to administer higher doses, more cycles of AVA6000, or more frequent dosing compared to doxorubicin"

It really is that simple!

[NicolaYJ @NicBongette]

@tom_the_bomb__ @RAH00084 @NicBasty Tom, they will but they will also be using this hashtag: #ifonlyihadboughtmore 🤣

#AVCT

[NicolaYJ @NicBongette]

It could be Alastair Smith talking, but it's Dr Tap - love the mirrored language.
#AVCT

https://t.co/pGi09nCLyM

[NicolaYJ @NicBongette]

@Ophidian18 Absolutely Ophidian. When I was chatting with AS at lunch, about other possible candidates, he gave a lovely knowing smile. He definitely wants to target the most toxic, dangerous warheads.
#AVCT

[NicolaYJ @NicBongette]

@MylesMcNulty @avacta Enjoy listening to it on line with a drink in hand. Your input will be missed today @MylesMcNulty.

[NicolaYJ @NicBongette]

@Turkstocks Great video from Avacta's CSO Dr Fiona McLaughlin at Bio International in Boston.
3 mins of gold! Well worth a watch. Thanks Turk.
#AVCT

[Avacta @avacta]

Watch the pre|CISION™ Mechanism of Action scientific animation video that describes the science behind Avacta’s pre|CISION™ tumour microenvironment activation platform. https://t.co/MdJPJUU70D #AVCT

[NicolaYJ @NicBongette]

@MylesMcNulty @avacta Myles, thank you for creating this document. It is so very generous of you.
I am sure I can message on behalf of many that your opinion is greatly respected.

#AVCT

[NicolaYJ @NicBongette]

@SNScreenwriter @Ophidian18 That's what I was just about to say Shaun 😄.
Great thread Ophidian, thank you.
I think we can all be unequivocally happy with our investment.
Looking forward to the next chapter of this amazing story.
#AVCT

[NicolaYJ @NicBongette]

@CapitalPmh @avacta Well done Paul, great interview. Huge thanks to AS for providing the update and today's wonderful news.

My favourite word of the whole interview was 'unequivocal'.

#AVCT

[NicolaYJ @NicBongette]

@Ophidian18 Ophidian, I'll quote you again, "after that it's just degrees of brilliant!"
Thanks for all your input - superb day for science.
#AVCT